We have accomplished a lot together during our first 25 years and impacted the lives of hundreds of thousands of patients. But what matters most now is what we do next. Thank you for trusting in us and helping make BTL an outstanding global company now and for decades to come.
/PRNewswire/

Landmark Study Evaluates Long-Term Results of BTL Vanquish Technology Four Years Post-Treatment

Body-Shaping Leader is Clinically Shown to Deliver Lasting Abdominal Circumferential Reduction
Learn More
/PRNewswire/

Landmark Study Evaluates Long-Term Results of BTL Vanquish Technology Four Years Post-Treatment

BTL Aesthetics, leader in non-invasive aesthetic treatments, is excited to share the findings of a newly published study that boasts long lasting benefits of noninvasive, radiofrequency (RF) energy—as used in the breakthrough BTL Vanquish and Vanquish ME devices—to achieve abdominal circumferential reduction. Evaluating results four years post-treatment, this study is a first-of-its-kind for the non-invasive space as it goes beyond the standard evaluation time period, further demonstrating the technology's ability to help impart a permanent reduction of fat within the area of treatment. 

While a rapidly growing category, non-invasive body shaping treatments are still fairly new to the market, making physicians and consumers alike eager for more long-term data. Until now, there has been very little scientific evidence published to document how fat reduction achieved through noninvasive RF treatment evolves over time, making the release of this four-year data significant for both BTL Aesthetics and the industry at large. 

"We're thrilled to have this four-year follow-up data, as most clinical studies only incorporate evaluations 3-12 months following the procedure, and has remained the industry standard for post-treatment assessment." shares Tomas Boleslavsky of BTL Aesthetics. "The use of BTL Vanquish technology within this study further speaks to the brand's leadership within the industry, as well as its impressive and sustainable treatment results."

This study evaluated 13 individuals who received the BTL Vanquish treatment four years (+60 days) prior, utilizing the same measurement markers as those at the 1-month follow-up visit in the original Journal of Drugs and Dermatology study. The study findings prove that patients preserved an average 75.2% of the original body contouring effect four years post treatment series as demonstrated by abdominal circumferential reduction. While the treatments cannot prevent any future weight gains, the data is significant as it boasts sustained treatment results and no long-term side effects.

"This is a milestone study for the industry, as evidence of how the results evolve over longer periods of time hadn't been studied" shared Dr. Klaus Fritz. "While we [physicians] have always known the effects of radiofrequency induced apoptosis are permanent, this study's findings clinically demonstrate just that, along with the fact that long term results of BTL Vanquish treatments can be sustained."

About BTL Industries

Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,350 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at http://www.btlaesthetics.com.

We are proud to announce that we are The Aesthetic Industry Winners 2017 in the "Best Non-Surgical Body Shaping Device" category with our new #BodyByBTL program.
/PRNewswire/

BTL Aesthetics' Award-Winning Technology Makes New Year's Resolutions Easy

Feel More Confident with the Body Shaping Devices Earning Top Honors in the Aesthetics Industry
Learn More
/PRNewswire/

BTL Aesthetics' Award-Winning Technology Makes New Year's Resolutions Easy

Weight loss is always a top New Year's resolution. But for everyone who knows that fad diets, exercise regimens and expensive topical creams just don't work in terms of fat reduction and skin laxity, BTL Aesthetics is your 2017 solution. Recognized as a leader among industry peers and top aesthetics institutions, BTL Aesthetics— and the non-invasive devices it manufactures—received six awards in the U.S. and eight globally in 2016.

"We are thrilled that our next-generation, smartly-designed devices have received this kind of industry recognition," said John Ferris, U.S. Marketing Director for BTL Aesthetics. "It was a record year for the company in terms of awards, and anyone looking to trim, tone and tighten in the New Year should know that devices from BTL Aesthetics are highly regarded in the industry and among some of the country's top physicians."

2016 Awards for BTL Aesthetics

  • Aesthetic Show: Best Non-Invasive Body Shaping Procedure, BTL Vanquish ME, BTL Exilis ULTRA and BTL Cellutone, Dr. Suneel Chilukuri
  • Aesthetic Academy: Best Non-Invasive Body Shaping Procedure, BTL Vanquish ME, Dr. Jason Emer
  • Aesthetic Everything: Top Shaping Company (No. 1); and a Top Ten Aesthetic Company
  • My Face My Body:
    • U.S.: Best Skin Tightening Procedure, BTL Exilis ULTRA
    • Outside the U.S.: Best Body Reshaping Procedure with BTL Vanquish ME
  • THE Aesthetic Guide: THE Aesthetic Industry Awards' Best New Combination Technology, BTL Exilis ULTRA
  • Aesthetic and Anti-Aging Medicine European Congress (AMEC) 2016: Best Cosmetic Gynecology Device, BTL INTIMA

Breakthrough Devices—from Fat Reduction, to Tightening and Toning:  
BTL Vanquish ME is a breakthrough, physician-favored fat reduction treatment that is FDA-cleared for the circumferential reduction of the abdomen and thighs. The treatment was also recently shown, in a peer-review study published in the Journal of Drugs and Dermatology, that it treats more fat faster—and over a much larger area—than its competitors on the market, and without pain or bruising. BTL Vanquish and BTL Vanquish ME are the only radiofrequency devices on the US Aesthetic market that allow for non-contact, hands-free treatment of subcutaneous fat. Committed to innovation, the company's second-generation BTL Vanquish ME device was also recently proven—in a recent published clinical study—to provide more consistent outcomes and to reduce abdominal fat thickness by 53% more than its predecessor.

Additionally, BTL Aesthetics was also first-to-market with the technology in BTL Exilis ULTRA. This device is the first FDA cleared device that simultaneously transmits radio frequency and ultrasound energy. The combination of energies help optimize the patient's experience, as therapeutic temperature can be reached faster, more comfortably, and with better outcomes than either modality alone.

BTL Vanquish ME, BTL Exilis ULTRA and BTL Cellutone treatments are available through a network of licensed physicians and medically supervised spas. Visit www.btlaesthetics.us/find-a-physician/ to find a physician.

About BTL Industries  
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,100 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at http://www.btlaesthetics.com.

About the Aesthetics Awards Referenced  
BTL Aesthetics won awards in 2016 from the following industry organizations: The Aesthetic Show, Aesthetic Academy, Aesthetic Everything, MyFaceMyBody, THE Aesthetic Guide, and the Aesthetic and Anti-Aging Medicine European Congress (AMEC).

/PRNewswire/
Clinicals Show: Patients Lost One-Quarter Liquid Gallon of Fat, on Average, with BTL Vanquish ME
Learn More
/PRNewswire/

BTL Aesthetics today announced the release of a clinical evaluation proving that its BTL Vanquish ME device was effectively redesigned for more efficient, predictable and homogenous energy delivery to the targeted tissue. The result: Significantly better outcomes in abdominal fat thickness reduction, 53% higher, with BTL Vanquish ME versus BTL Vanquish.

"We are committed to providing our physician network and their patients with the most highly-advanced devices on the market," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "These clinical results, showing that our smartly-designed, next-generation device outperformed its predecessor, really speak to BTL Aesthetics' innovative approach and entrepreneurial spirit."

Background:

BTL Vanquish launched in 2013, was a breakthrough device for noninvasive fat reduction. Not stopping there, BTL Aesthetics' commitment to an innovative approach quickly resulted in the development of BTL Vanquish ME (Maximum Energy), which debuted in 2015. BTL Vanquish ME is a physician-favored fat reduction treatment that is FDA-cleared for the circumferential reduction of the abdomen and thighs. The treatment was also recently shown, in a peer-review study published in the Journal of Drugs and Dermatology, that it treats more fat faster—and over a much larger area—than its competitors on the market. BTL Vanquish and BTL Vanquish ME are the only radiofrequency devices on the US Aesthetic market that allow for non-contact, hands-free treatment of subcutaneous fat.

About the Clinical Study:

The multi-center study, conducted by Drs. Nicole Hayre, Peter Jenkin and Melanie Palm, sought to compare clinical outcomes of a noninvasive selective radiofrequency (RF) field device (BTL Vanquish ME) with its predecessor (BTL Vanquish). A total of 36 subjects with BMIs under 30 but above 24, were randomly assigned to be treated in Group A (BTL Vanquish ME) or Group B (Vanquish) to obtain a side-by-side comparison of the devices' efficacies. Each subject received four, once-weekly, 45-minute treatments with their group's determined device. Measurements of subjects' abdominal fat were taken prior to the first treatment and again four weeks after finishing the final treatment. Subjects had also been instructed to maintain their usual diet and lifestyle throughout the duration of the study.

Results

Abdominal fat layer thickness reduction at 30 days post treatment was the primary outcome measurement in the study as measured by ultrasound. The degree in fat layer thickness between Group A and B was statistically significant (p<0.008), and data showed that fat for Group A (BTL Vanquish ME) and Group B (BTL Vanquish) was reduced by 29.5% and 15.2%, respectively. That represents a 53% higher reduction of abdominal fat layer thickness with Group A than for those in Group B. Every subject in the study showed a reduction in the abdominal fat layer thickness.

-       Group A: Reduction ranged from 2.0 to 6.6 mm (average of 4.17 ±1.42 mm)
-       Group B: Reduction ranged from .07 to 10.4 mm (average of 2.72 ± 2.21 mm)

The standard deviation of ultrasound measurements in Groups A and B were 1.42 mm and 2.21 mm, respectively—and this reduction in standard deviation of fat reduction measurements in Group A vs Group B is evidence that the BTL Vanquish ME provides more consistent performance.

Finally, using the measured reduction in fat layer thickness and the treatment surface area of the applicator (2100 cm2or 325.5 square inches), a reduction of 0.876 liter (0.23 liquid gallon) and 0.571 liter (0.15 liquid gallon) of fat were calculated for Groups A and B, respectively.  (Volume lost = fat layer thickness reduction x effective area or spot size of the applicator (2100 cm2; 325.5 square inches).  This assumes an homogenous response to treatment.

Further speaking to its uniqueness in the market, the BTL Vanquish ME device holds three patents: One, granted in 2013, protects the non-contact method of adipose tissue treatment. The second, issued in September 2016, is for the feedback power control device for non-invasive treatment of skin and human tissue. The third—issued in October—refers to a new method for treating subcutaneous tissue that positions one or more applicators adjacent to the skin of a patient, but not touching the skin or in need of continual movement by the applicator. These applicators, which transmit electromagnetic energy into the skin where it can be used for subcutaneous tissue treatment, may also be used for tightening the skin and for remodeling collagen tissue in the subcutaneous tissue. Additionally, airflow can be provided between the applicator and the skin by positioning an air mover (attached or made part of the applicator) close to the skin.

BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit www.btlvanquishme.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,100 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis Ultra, and BTL Cellutone.

/PRNewswire/

For 'Hands-Free' Body Contouring, BTL Vanquish ME is the Hands-Down Winner

Journal Review of Top Body Contouring Devices Shows BTL Vanquish ME Removes Fat Faster, and Over a Greater Coverage Area
Learn More
/PRNewswire/

For 'Hands-Free' Body Contouring, BTL Vanquish ME is the Hands-Down Winner

BTL Aesthetics today announced the release of a peer review study, published in the Journal of Drugs in Dermatology (JDD), addressing effectiveness and patient satisfaction of three "hands-free" noninvasive body contouring devices: cryolipolysis, 1060nm diode laser, and BTL Vanquish ME. The study, written by Drs. Suneel Chilukuri and Gregory Meuller, analyzed peer reviewed studies on the three devices and their mechanism of action, as well as on their evidence of safety and efficacy.

Based on the facts presented, BTL Vanquish ME was proven to be more cost effective and to remove fat faster—three to five times more speed coverage, per treatment regimen—over a higher coverage area.

/PRNewswire/

Getting a Leg Up on Body Shaping: BTL Aesthetics Announces FDA Clearance for Thighs

BTL Vanquish ME is clinically shown to simultaneously slim the inner and outer thighs
Learn More
/PRNewswire/

Getting a Leg Up on Body Shaping: BTL Aesthetics Announces FDA Clearance for Thighs

BTL Aesthetics today announced that it has received a new designation from the Food &
Drug Administration (FDA) for its award-winning, non-invasive fat reduction treatment, BTL Vanquish ME. The physician-favored treatment is now FDA-cleared for the circumferential reduction of the abdomen and thighs. The clearance was secured following several rounds of clinical testing to provide ample evidence of its efficacy and safety—which has also been previously documented thanks to two studies published in peer-reviewed journals.   

"We're excited to receive our latest FDA clearance, as it further demonstrates the versatility of the BTL Vanquish ME system and its efficacy," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "This clearance, which was secured in part thanks to extensive clinical research, is truly a further testament to BTL Vanquish ME's superior and consistent results."

Harnessing the power of high-frequency, Selective RF energy, BTL Vanquish ME induces death of fat cells through apoptosis, and the body flushes fat cells out of the body naturally to help slim the abs, belly, love handles, and now thighs. Boasting the largest spot size in the industry, the unique contactless panel allows patients to treat a broad area at once, resulting in more even results with no lines of demarcation. Similarly to treatment of the abdomen, which covers the core from flank-to-flank, the Flex Applicator—specially designed to treat and adjust to the thighs—simultaneously slims both the inner/outer thighs and saddle bags. This allows for enhanced patient outcomes, shorter treatment times and elimination of additional consumable costs for the physician—a sharp contrast to similar systems which focus solely on smaller areas or specific fat deposits, making BTL Vanquish ME a more affordable treatment option.

"The upper legs continue to be a common area of complaint for my patient base, with many inquiring about procedures to help slim, shape, and tone thighs," says Dr. Annie Chiu, Board Certified Dermatologist and founder of The Derm Institute in Redondo Beach, CA. "With the BTL Vanquish ME Flex Applicator at my practice, we have been able to treat both the inner and outer thigh in each session at the same time, giving patients a circumferential reduction in their thighs and a slimmer leg appearance," added Chiu.

This newest distinction further supports previous studies published in peer-reviewed journals including Dermatologic Therapy and the Journal of Drugs and Dermatology both of which highlight the effectiveness of BTL Aesthetics' patented radio frequency technology to reduce the circumference of thighs. In clinical studies, over 80% of subjects experienced a statistically high and significant circumferential reduction with four, 30-minute treatment sessions per leg, delivered once a week over a four week period. BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit btlaesthetics.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL Industries is a privately owned developer and manufacturer of medical and aesthetic equipment. BTL currently has over 1,050 employees and direct offices in more than 53 countries. BTL Aesthetics, a division of BTL, has revolutionized the way to non-invasively remove adipose tissue; it currently ranks 2nd among the non-invasive body shaping and tightening manufacturers globally. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis Ultra, and BTL Cellutone.

BTL Vanquish ME™ Flex Applicator, a Pain-Free Approach to Reduce Fat around the Thighs and Saddle Bags is now FDA cleared!

Learn More

BTL Vanquish ME™ Flex Applicator, a Pain-Free Approach to Reduce Fat around the Thighs and Saddle Bags is now FDA cleared!

The noninvasive Flex applicator eliminates unwanted fat by delivering RF thermal energy to the target body area without touching the skin. By hovering over the upper legs, the device selectively destroys fat cells in deep tissue to redefine thighs and saddlebags. With four weekly treatments, patients can expect to enjoy tighter, thinner thighs.

Comfortable, safe, and noninvasive solution – no anesthesia, pain medication or downtime is required for treatment. Short 30-minute sessions - generally scheduled one week apart over four to six weeks. Affordable and convenient – return immediately to routine activities. Find your nearest BTL Vanquish ME™ operator at Find a Physician - http://www.btlaesthetics.us/find-a-physician

/PRNewswire/

Trimmed, Tightened and Toned: BTL Aesthetics Unveils New Innovations

Next generation BTL Exilis ULTRA and BTL Cellutone, continue to revolutionize the industry
Learn More
/PRNewswire/

Trimmed, Tightened and Toned: BTL Aesthetics Unveils New Innovations

BTL Aesthetics, the manufacturers of BTL Vanquish ME – an award-winning, non-invasive fat reduction treatment – today announced the introduction of three new products that take body shaping and skin toning to the next level.

"As a leader in aesthetics innovation, we're always looking for new ways to help our physician partners achieve optimal results," said Jan Zarsky, Director of North America for BTL Aesthetics. "The addition of BTL Exilis ULTRA – the only system with simultaneous delivery of radio frequency and ultrasound - helps raise the bar in combination therapy. BTL Cellutone, when used in conjunction with BTL Vanquish ME, delivers what physicians are referring to as the "shock and awe" affect, as the two-part treatment is helping to enhance patient's experience, while achieving consistent and fast results," added Zarsky.

BTL Exilis ULTRA

Taking the company's widely used body shaping and skin rejuvenating treatment, Exilis, to the next level; BTL Exilis ULTRA is the first non-invasive aesthetic device to simultaneously deliver ultrasound and radio frequency energy. The combination of energies help to optimize the patient's experience, as therapeutic temperature can be reached faster than either modality alone. Additionally the design of the applicator is unique in the fact it has a cooling tip to allow physicians to adjust the level of penetration for enhanced results, as well as make the treatment extremely versatile.

"I've been very impressed by BTL Exilis ULTRA as it allows me to utilize these dual modalities (radio frequency and ultrasound) in new ways," said Dr. Suneel Chilukuri, Cosmetic and Dermatologic Surgeon in Houston, TX. "In addition to seeing great results on the arms and neck, which are challenging areas to treat, I'm also utilizing it to rejuvenate lips. In fact, patients have seen such positive results, that they're looking to come in sooner to have additional areas treated." added Chilukuri.

BTL Cellutone

Utilizing targeted vibrations, BTL Cellutone can be used as a stand-alone device or in combination with other aesthetic therapies such as non-invasive fat reduction and tightening treatments. BTL Vanquish ME utilizes selective radio frequency energy to heat and ultimately destroy fat cells which are then removed from the body naturally. When paired with BTL Cellutone, the patients experience is significantly improved thanks to its oscillating massage therapy, as it helps increase blood supply, resulting in better lymphatic drainage and improved elimination of fat cells.

"My practice has been using BTL Cellutone in conjunction with BTL Vanquish ME for treatment of both the abdomen and thighs. The combination therapy has helped improve skin texture and tightening, as well as deliver faster circumferential reduction, so much so that I am seeing results as early as 3 sessions compared to what I used to see weeks after four treatments," said Board Certified Cosmetic and General Dermatologist, Annie Chiu, based in Redondo Beach, CA. "The treatment is also well tolerated with patients, and the addition of Cellutone appeals to these same patients with the improved skin appearance," added Chiu.

BTL Exilite

Tapping into the resurfacing ability of IPL (Intense Pulse Light), BTL expands its treatment and combination therapy portfolio with the launch of a customizable IPL device. BTL Exilite will help physicians address vascular and pigmented lesions, hair removal and acne. When combined with radio frequency in the BTL Exilis treatment, it will allow for targeted tightening, plus resurfacing, which is an ideal complement to the "liquid facelifts" being performed in office.

"I have found the new BTL Exilite to be an easy transition from our other pulsed light systems. Treatments are fast, well tolerated and effective," said Jeffrey Hunt, D.O., R.V.S., R.V.P.I., out of Tampa Bay, FL. "BTL Aesthetics has put together a winning combination of features in their new IPL. The system offers plenty of power, custom treatment parameter settings and speed to perform effective IPL treatments," added Hunt.

BTL Cellutone, BTL Exilis ULTRA, BTL Exilite and BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit btlaesthetics.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL Industries is a privately owned developer and manufacturer of medical and aesthetic equipment. BTL currently has over 1,050 employees and direct offices in more than 53 countries.

BTL Aesthetics, a division of BTL, has revolutionized the way to non-invasively remove adipose tissue; it currently ranks 2nd among the non-invasive body shaping and tightening manufacturers globally. BTL Aesthetics' brands include BTL Exilis Elite, BTL Vanquish ME, and BTL Exilite.

We are proud to announce that BTL Exilis Protégé has won the prestigious Harper´s Bazaar Singapore 2016 Best Face Contouring Treatment. Learn more about this great wrinkle reduction and skin rejuvenation product at tinyurl.com/zfpbaoe. Read the Harper´s Bazaar article about 2016 Spa Awards at tinyurl.com/j486gbl.
Visit Site
/PRNewswire/

BTL Aesthetics Continues to Set the Standard in Body Contouring Treatment

New study demonstrates clinical efficacy and safety of BTL Vanquish for circumferential reduction of waistline in multiple body types.
Learn More
/PRNewswire/

BTL Aesthetics Continues to Set the Standard in Body Contouring Treatment

BTL Aesthetics today announced the release of a new study which further demonstrates the superior results of body shaping leader, BTL Vanquish, a radio frequency treatment that offers patients a solution to reducing stubborn fat around the midsection and effectively improves contouring of the abdomen and love handles. The study, conducted by board certified plastic surgeon, Amir Morandi, MD and board certified dermatologist, Melanie Palm, MD, aimed to determine the efficacy and safety of the popular protocol.

The study found that subjects experienced an average of 1.7 inch reduction in abdominal circumference following a controlled series of treatments with BTL Vanquish. This reduction was specifically noteworthy as the results were similar to a previous study conducted of 40 participants with an overall higher BMI on average, demonstrating that the treatment is beneficial for a variety of body types, including those with lower BMI levels. Additionally, in order for the study to be considered effective, the physicians were also looking for a statistically significant reduction in circumference three months following treatment in order to show the permanent destruction of fat cells, which was concluded as effective for the subjects in this study.

"As a practicing cosmetic dermatologist, seeing a significant reduction in subjects with a lower BMI was particularly impressive to me as it shows how BTL Vanquish is also a reliable option for more active patients, especially those who need that little extra boost to remove lingering or stubborn fat to further support a healthy lifestyle," said Dr. Palm. "The results also show the continued advancements in radio frequency technology, as I personally see radio frequency as the next big wave in cosmetic dermatology," added Dr. Palm.

The study was conducted on 24 subjects, primarily female, ranging from 30-69 in age, who all received four weekly 45-minute radio frequency treatments targeting the abdomen area and love handles. Results were tracked through standardized digital photographs and circumference measurements, and compared to biometric measurements such as weight, hydration and body fat collected at baseline and each study visit. In addition, 4 subjects were randomly selected for serum lipid and liver-related blood tests at baseline and periodically throughout treatment and follow up visits to determine safety.

"As a company committed to innovation, we're excited by the impressive results we're continuing to see through additional testing of our Vanquish device," said Jan Zarsky, Director of North America of BTL Aesthetics. "With the continued support of our valued physician partners, and recent introduction of the next generation, BTL Vanquish ME, we're confident that we'll continue to impress patients with safe and visible results," added Zarsky.

BTL Vanquish and Vanquish ME utilize patented, non-invasive and painless radiofrequency technology to reduce fat in the core and abdomen. Featuring the industry's largest treatment spot size, the newly released BTL Vanquish ME is designed to treat the whole abdomen from flank to flank during one session for faster, smoother results. BTL Vanquish ME is clinically shown to be an efficacious and repeatable procedure for those looking to eliminate belly fat and love handles without surgery.

BusinessWire

BTL Vanquish ME™: BTL Aesthetics Introduces Next Generation Fat Reduction Technology

FDA-Cleared BTL Vanquish ME Redefines Body Contouring with Enhanced Features for Consistent Results of a Trimmed Waistline
Visit Site
BusinessWire

BTL Vanquish by BTL Industries Receives FDA Clearance for Non-Surgical Circumferential Reduction of the Abdomen

BTL Vanquish is the World’s Only Operator-Independent Radio Frequency Device to Reduce Circumference of the Waistline
Learn More
BusinessWire

BTL Vanquish by BTL Industries Receives FDA Clearance for Non-Surgical Circumferential Reduction of the Abdomen

BTL Vanquish is the World’s Only Operator-Independent Radio Frequency Device to Reduce Circumference of the Waistline

BTL Industries, a leading manufacturer of devices for medical and aesthetic use, announced the FDA clearance of its groundbreaking BTL Vanquish device for circumferential reduction of the abdomen area. The system’s patented technology creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue. Further, BTL Vanquish provides optimal aesthetic results across the entire abdominal area with maximum safety and comfort without surgery or downtime.

“FDA clearance of Vanquish is a significant step forward in providing the newest treatment option for body slimming and shaping.”

“BTL Vanquish is truly a breakthrough technology. Published clinical studies show it permanently destroys unwanted fat for safe and measurable circumferential reduction of the abdominal area without the cost and inconvenience of surgery,” says David McDaniel, MD, a leading dermatologist and investigator of high-tech devices for non-invasive body contouring. “FDA clearance of Vanquish is a significant step forward in providing the newest treatment option for body slimming and shaping.”

BTL Vanquish is radically different from other systems that use a point source of heat or cold. Instead, BTL Vanquish uses a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application. Providing a clinically proven and safe treatment option without touching the patient’s skin, the breakthrough technology of BTL Vanquish surpasses earlier treatment options that require uncomfortable suction or labor-intensive application. The BTL Vanquish achieves results that all patients want -- a beautifully contoured abdomen and smaller waistline.

“FDA clearance of BTL Vanquish marks a defining moment in our journey to provide physicians and their patients an elegant treatment option to target fat cells and bring about a reduction in the waist circumference,” said Andrea Morrison, BTL’s Director of Clinical Development. “BTL is proud to offer patients a comfortable, affordable and noninvasive body shaping experience. This regulatory milestone underscores BTL’s commitment to deliver meaningful solutions to aesthetic patient care.”

We are pleased to announce the launch of our brand new international corporate website www.btlnet.com.

Visit Site

BTL EXILITE (IPL) received the FDA clearance for reduction of pigmented and vascular lesions, acne therapy and permanent reduction in hair regrowth.

/PRNewswire/
BTL Industries, Ltd., a world leader in skin tightening, body contouring and fat removal, announced that oral presentations by leading aesthetic specialists will be made at the AAD Meeting on March 20-23, 2015, in San Francisco. Device demos and musical photo opportunities featuring Exilis ELITE and Vanquish Flex RF Technology will be available at Exhibit Booth #2534.
Visit Site
/PRNewswire/
BTL Exilis ELITE was first introduced in February 2011 as a high-performance, non-invasive and pain-free treatment to reduce wrinkles and rejuvenate skin using ultra-precise radiofrequency technology. Now, the FDA has cleared the use of the award-winning technology for temporary reduction in the appearance of cellulite.
Visit Site

BTL’s Exilis device received US FDA clearance for a temporary reduction in the appearance of cellulite.

BTL’s Vanquish device received Korean FDA clearance for waist circumferential reduction.

BTL Aesthetics is the Aesthetics Awards WINNER 2014 for the 'BEST EQUIPMENT SUPPLIER of the Year'!